Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01491737 |
|---|---|
| Brief Title: | A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer (PERTAIN) |
| First Submitted : | December 6, 2011 |
| First Submitted that Met QC Criteria : | December 12, 2011 |
| First Posted : | December 14, 2011 (Estimate) |
| Results First Submitted : | May 11, 2017 |
| Results First Submitted that Met QC Criteria : | May 11, 2017 |
| Results First Posted : | June 7, 2017 |
| Last Update Submitted that Met QC Criteria : | October 6, 2020 |
| Last Update Posted : | October 28, 2020 |